Search research articles
Contact Us
Filters
Showing results (231-240 of 407) with videos related to
Page
of 41
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 1, 1995
Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease
E D Louis, J E Goldman, J M Powers, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 1, 1993
Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders
M F Gordon, R Diaz-Olivo, A L Hunt, et al.
Neurology
|
September 1, 1975
Normalization of brain serotonin by L-tryptophan in levodopa-treated rats
S Fahn, S Snider, A L Prasad, et al.
Archives of Neurology
|
October 1, 1974
Normal pressure hydrocephalus and hypertensive cerebrovascular disease
M P Earnest, S Fahn, J H Karp, et al.
Archives of Neurology
|
February 1, 1985
Acetylcholinesterase activity in patients with torsion dystonia. Measurement in erythrocyte membranes
W A Maltese, S Bressman, S Fahn, et al.
Clinical Neuropharmacology
|
January 1, 1986
Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide
M N Hassan, A Reches, C Kuhn, et al.
The New England Journal of Medicine
|
July 24, 1975
Letter: Pain, paresthesia and parkinsonism
S R Snider, S Fahn, L J Cote, et al.
The Journal of Nervous and Mental Disease
|
February 1, 1971
A case with Gilles de la Tourette's syndrome: recurrent refractoriness to haloperidol, and unsuccessful treatment with L-dopa
J N DiGiacomo, S Fahn, J B Glass, et al.
Archives of General Psychiatry
|
January 1, 1971
Mental effects of high-dosage levodopa
C P O'Brien, J N DiGiacomo, S Fahn, et al.
Life Sciences
|
July 5, 1982
The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain
A Reches, H R Wagner, D Jiang, et al.
Page
of 41
Search research articles
Search
Showing results (231-240 of 407) with videos related to
Sort By:
Page
of 41
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 1, 1995
Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease
E D Louis, J E Goldman, J M Powers, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 1, 1993
Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders
M F Gordon, R Diaz-Olivo, A L Hunt, et al.
Neurology
|
September 1, 1975
Normalization of brain serotonin by L-tryptophan in levodopa-treated rats
S Fahn, S Snider, A L Prasad, et al.
Archives of Neurology
|
October 1, 1974
Normal pressure hydrocephalus and hypertensive cerebrovascular disease
M P Earnest, S Fahn, J H Karp, et al.
Archives of Neurology
|
February 1, 1985
Acetylcholinesterase activity in patients with torsion dystonia. Measurement in erythrocyte membranes
W A Maltese, S Bressman, S Fahn, et al.
Clinical Neuropharmacology
|
January 1, 1986
Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide
M N Hassan, A Reches, C Kuhn, et al.
The New England Journal of Medicine
|
July 24, 1975
Letter: Pain, paresthesia and parkinsonism
S R Snider, S Fahn, L J Cote, et al.
The Journal of Nervous and Mental Disease
|
February 1, 1971
A case with Gilles de la Tourette's syndrome: recurrent refractoriness to haloperidol, and unsuccessful treatment with L-dopa
J N DiGiacomo, S Fahn, J B Glass, et al.
Archives of General Psychiatry
|
January 1, 1971
Mental effects of high-dosage levodopa
C P O'Brien, J N DiGiacomo, S Fahn, et al.
Life Sciences
|
July 5, 1982
The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain
A Reches, H R Wagner, D Jiang, et al.
Page
of 41